IGI Logo

Road to recovery by H2FY27

Q1FY27 continues to highlight the gap between Praj Industries’ (PRJ IN) long-term growth initiatives and its near-term earnings contribution. While the company is expanding into newer businesses, these opportunities remain in the nascent stage and are yet to meaningfully offset weakness in the core business. Continued project delays, subdued operating leverage, and ongoing investments in GenX are likely to keep profitability under pressure in the near term. Expected benefits from newer segments and internationalization targeted by the latter half of FY27 will depend on timely project execution and scaling, while management’s lack of margin guidance reflects limited visibility on the pace of recovery. We retain Sell with a TP of INR 285 based on 27x FY28E P/E.

Revenue momentum sustained amid weak margin:

Q1FY27 performance was mixed, with revenue growth remaining healthy but profitability under pressure. Consolidated revenue increased 11.8% YoY to INR 7.2bn, led by growth in bioenergy and HiPurity, while engineering remains subdued and domestic first-generation ethanol execution continues to be affected by weak Greenfield activity, customer funding constraints, and slower backlog conversion. EBITDA declined 15.7% YoY to INR 300mn, with a margin contracting 137bp to 4.2%, reflecting subdued volume and an adverse revenue mix; rising steel and raw material cost remains a headwind. The rise in share of the African Union (AU) market exports revenue with lower realization and margin vs the EU and the Americas. Despite weak operating leverage, PAT was up 117.3% YoY to INR 116mn, supported by higher Other income and lower interest cost

International orders offset domestic ethanol weakness:

Order intake rebound to INR 10.0bn in Q1FY27, up 25.8% YoY, driven by the international markets and newer applications, with exports contributing 43% of Q1 intake and a marquee 800 KLPD corn-to-ethanol order from Brazil. Meanwhile, Compressed Biogas (CBG) provides a INR 230bn medium-term growth opportunity, following the GOBARdhan scheme, project finalization, and feedstock availability remain key bottlenecks. Beyond bioenergy, PRJ is gradually diversifying through GenX, which has secured a global hyperscale data-center supply agreement, and opportunities emerging in semiconductors, batteries & solar. Overall, INR 45.9bn order backlog and 1.4x book-to-bill provide revenue visibility, but meaningful earnings acceleration may depend on faster conversion and a greater contribution from higher-margin international, services, and newer biofuel businesses. However, the quality of near-term conversion remains mixed, as domestic first-generation ethanol projects continue to face subdued Greenfield activity, customer funding constraints, and slower backlog conversion.

Retain Sell with a TP of INR 285:

Management remains constructive on FY27 order recovery, but near-term momentum remains constrained by subdued domestic Greenfield ethanol activity, and delayed project conversion. Growth is increasingly dependent on international orders and newer segments, such as data centers, semiconductors, Sustainable Aviation Fuel (SAF), and CBG scaling up; hence, we retain Sell with a TP of INR 285 based on 27x FY28E P/E.

Please refer disclaimer at Report
SEBI Registration number is INH000000933